Song He1, Xiaobing Miao1, Yaxun Wu1, Xinghua Zhu1, Xianjing Miao2, Haibing Yin1, Yunhua He2, Chunsun Li1, Yushan Liu1, Xiaoyun Lu1, Yali Chen1, Yuchan Wang3, Xiaohong Xu4. 1. Department of Pathology, Affiliated Cancer Hospital of Nantong University, Nantong, 226361, Jiangsu, China. 2. Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, 226001, Jiangsu, China. 3. Jiangsu Province Key Laboratory for Inflammation and Molecular Drug Target, Nantong University, Nantong, 226001, Jiangsu, China. wangyuchannt@126.com. 4. Department of Oncology, Affiliated Cancer Hospital of Nantong University, Nantong, 226361, Jiangsu, China. xuxiaohongnantong@126.com.
Abstract
BACKGROUND: The Karyopherin proteins are involved in the shuttling of cargo proteins, and certain RNAs, across the nuclear pore complex into and out of the cell nucleus. Karyopherin β1 (Kpnβ1) is a member of the Karyopherin β superfamily of nuclear transport proteins. In addition to the nuclear import function, Kpnβ1 is associated with the occurrence of tumors. This study investigated the expression and biologic function of Kpnβ1 in diffuse large B-cell lymphoma (DLBCL). METHODS: The prognostic value of Kpnβ1 expression was evaluated using immunohistochemical staining. The role of Kpnβ1 on cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) was also determined. RESULTS: We demonstrated that Kpnβ1 mRNA and protein expression levels were significantly higher in DLBCL B-cells and DLBCL cell lines than in normal CD19 purified B-cells. Immunohistochemical analysis suggested that the expression of Kpnβ1 was correlated with Ki-67 (P < 0.001). Kaplan-Meier curve showed that high expression of Kpnβ1 was significantly associated with shorter overall survival. In addition, Kpnβ1 was associated with the proliferation of DLBCL cells. Importantly, we found that Kpnβ1 could interact with p65 and promote CAM-DR via accelerating NF-κB activation in DLBCL. CONCLUSIONS: Patients with tumors highly expressing Kpnβ1 have poorer overall survivals. Kpnβ1 interacts with p65 and enhances CAM-DR.
BACKGROUND: The Karyopherin proteins are involved in the shuttling of cargo proteins, and certain RNAs, across the nuclear pore complex into and out of the cell nucleus. Karyopherin β1 (Kpnβ1) is a member of the Karyopherin β superfamily of nuclear transport proteins. In addition to the nuclear import function, Kpnβ1 is associated with the occurrence of tumors. This study investigated the expression and biologic function of Kpnβ1 in diffuse large B-cell lymphoma (DLBCL). METHODS: The prognostic value of Kpnβ1 expression was evaluated using immunohistochemical staining. The role of Kpnβ1 on cell proliferation- and cell adhesion-mediated drug resistance (CAM-DR) was also determined. RESULTS: We demonstrated that Kpnβ1 mRNA and protein expression levels were significantly higher in DLBCL B-cells and DLBCL cell lines than in normal CD19 purified B-cells. Immunohistochemical analysis suggested that the expression of Kpnβ1 was correlated with Ki-67 (P < 0.001). Kaplan-Meier curve showed that high expression of Kpnβ1 was significantly associated with shorter overall survival. In addition, Kpnβ1 was associated with the proliferation of DLBCL cells. Importantly, we found that Kpnβ1 could interact with p65 and promote CAM-DR via accelerating NF-κB activation in DLBCL. CONCLUSIONS:Patients with tumors highly expressing Kpnβ1 have poorer overall survivals. Kpnβ1 interacts with p65 and enhances CAM-DR.
Entities:
Keywords:
Cell adhesion-mediated drug resistance (CAM-DR); Diffuse large B-cell lymphoma (DLBCL); Kpnβ1; NF-κB p65; Proliferation
Authors: Lina Odqvist; Santiago Montes-Moreno; Roxana E Sánchez-Pacheco; Ken H Young; Esperanza Martín-Sánchez; Laura Cereceda; Lydia Sánchez-Verde; Raquel Pajares; Manuela Mollejo; Manuel F Fresno; Francisco Mazorra; Carmen Ruíz-Marcellán; Margarita Sánchez-Beato; Miguel A Piris Journal: Mod Pathol Date: 2014-03-07 Impact factor: 7.842
Authors: Pauline J van der Watt; Christopher P Maske; Denver T Hendricks; M Iqbal Parker; Lynette Denny; Dhirendra Govender; Michael J Birrer; Virna D Leaner Journal: Int J Cancer Date: 2009-04-15 Impact factor: 7.396
Authors: Chi Young Ok; Zijun Y Xu-Monette; Alexandar Tzankov; Dennis P O'Malley; Santiago Montes-Moreno; Carlo Visco; Michael B Møller; Karen Dybkaer; Attilio Orazi; Youli Zu; Govind Bhagat; Kristy L Richards; Eric D Hsi; J Han van Krieken; Maurilio Ponzoni; John P Farnen; Miguel A Piris; Jane N Winter; L Jeffrey Medeiros; Ken H Young Journal: Cancer Date: 2014-03-19 Impact factor: 6.860
Authors: Laura Di Francesco; Annalisa Verrico; Italia Anna Asteriti; Paola Rovella; Pietro Cirigliano; Giulia Guarguaglini; Maria Eugenia Schininà; Patrizia Lavia Journal: Sci Rep Date: 2018-01-30 Impact factor: 4.379